McKesson Corporation is expanding its drug development and commercialization capacity to the tune of $2.25 billion. | The ...

Jazz Pharmaceuticals’ bispecific antibody Ziihera has gained an FDA approval for first-line HER2-positive stomach cancer, ...

Bausch + Lomb has come up short in a phase 2 trial, testing its combination of dry eye disease drugs Xiidra and Miebo. | ...

Just 16 months after Johnson & Johnson scored its initial FDA app | Sixteen months after Johnson & Johnson scored its initial ...

On Monday, the U.S. Court of Appeals for the Third Circuit in Washington, D.C., ruled against Merck & Co., rejecting its ...

Hansa has operated as a commercial-stage drugmaker since 2020, when the European Union cleared the way for imlifidase for ...

Eli Lilly is drawing attention to a lifelong journey of obesity struggles in its new campaign linked to GLP-1 Medicare access ...

With its ascent seemingly unstoppable in the last few years, automated cell therapy manufacturer Cellares is facing some ...

HHS Secretary Robert F. Kennedy Jr. has joined President Donald Trump in a renewed effort to challenge how the United States ...

Daiichi Sankyo is promoting Ken Keller to lead a new globally integrated commercialization unit, putting the executive in ...

Move over, Hollywood—the real stars of the show are the ones helping patients in hospitals across the country.  | Education ...

If at first you don’t succeed in gene therapy, then try, try again. | If at first you don’t succeed in gene therapy, then try ...